Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schairer

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Epidemiologic Reviews|January 1, 1993
Estrogen replacement therapy and breast cancer riskL A Brinton, C Schairer
The New England Journal of Medicine|June 19, 1997
Postmenopausal hormone-replacement therapy--time for a reappraisal?L A Brinton, C Schairer
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|August 1, 1990
Comparison of jobs, exposures, and mortality risks for short-term and long-term workersP A Stewart, C Schairer, A Blair
International Journal of Cancer|July 29, 1996
Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohortI Persson, J Yuen, L Bergkvist, et al.
Journal of Clinical Epidemiology|August 16, 2000
Risk of myocardial infarction after oophorectomy and hysterectomyM Falkeborn, C Schairer, T Naessén, et al.
American Journal of Epidemiology|October 1, 1986
Methylxanthines and benign breast diseaseC Schairer, L A Brinton, R N Hoover
International Journal of Cancer|October 15, 1987
Methylxanthines and breast cancerC Schairer, L A Brinton, R N Hoover
Scandinavian Journal of Work, Environment & Health|April 1, 2000
Comparison of industrial hygienists' exposure evaluations for an epidemiologic studyP A Stewart, R Carel, C Schairer, et al.
International Journal of Epidemiology|December 1, 1988
Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogensL Bergkvist, I Persson, H O Adami, et al.
Epidemiology (Cambridge, Mass.)|January 1, 1997
Cause-specific mortality in women receiving hormone replacement therapyC Schairer, H O Adami, R Hoover, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Epidemiologic Reviews|January 1, 1993
Estrogen replacement therapy and breast cancer riskL A Brinton, C Schairer
The New England Journal of Medicine|June 19, 1997
Postmenopausal hormone-replacement therapy--time for a reappraisal?L A Brinton, C Schairer
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|August 1, 1990
Comparison of jobs, exposures, and mortality risks for short-term and long-term workersP A Stewart, C Schairer, A Blair
International Journal of Cancer|July 29, 1996
Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohortI Persson, J Yuen, L Bergkvist, et al.
Journal of Clinical Epidemiology|August 16, 2000
Risk of myocardial infarction after oophorectomy and hysterectomyM Falkeborn, C Schairer, T Naessén, et al.
American Journal of Epidemiology|October 1, 1986
Methylxanthines and benign breast diseaseC Schairer, L A Brinton, R N Hoover
International Journal of Cancer|October 15, 1987
Methylxanthines and breast cancerC Schairer, L A Brinton, R N Hoover
Scandinavian Journal of Work, Environment & Health|April 1, 2000
Comparison of industrial hygienists' exposure evaluations for an epidemiologic studyP A Stewart, R Carel, C Schairer, et al.
International Journal of Epidemiology|December 1, 1988
Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogensL Bergkvist, I Persson, H O Adami, et al.
Epidemiology (Cambridge, Mass.)|January 1, 1997
Cause-specific mortality in women receiving hormone replacement therapyC Schairer, H O Adami, R Hoover, et al.
Pageof 8